O-039 Preliminary results of the cerevasc eShunt implant in the treatment of normal pressure hydrocephalus

ConclusionIn elderly patients affected by NPH and its insidious effect on mobility, cognition and urinary continence, our results show that the endovascular transdural eShunt device can be safely implanted with an acceptable risk profile and with rapid significant improvement in functional outcome scores. These early follow-up results suggest a potential future role for the less invasive percutaneous endovascular approach provided by the eShunt system in the NPH patient population.Abstract O-039 Figure 1Timed Up & Go (TUG) gait assessment in patients following CereVasc eShunt@ implant placement at follow-up compared to pre-procedure baseline (100%)Disclosures P. Lylyk: 2; C; CereVasc Inc. 3; C; CereVasc Inc. C. Matouk: None. A. Siddiqui: None. I. Lylyk: None. C. Bleise: None. E. Scrivano: None. N. Lylyk: None. J. Antonios: None. B. Beneduce: 5; C; CereVasc Inc. E. Levy: None. C. Heilman: 2; C; CereVasc Inc. 4; C; CereVasc Inc. A. Malek: 2; C; CereVasc Inc. 4; C; CereVasc Inc.

Source: Journal of NeuroInterventional Surgery - July 30, 2023 Category: Neurosurgery Authors: Lylyk, P., Matouk, C., Siddiqui, A., Lylyk, I., Bleise, C., Scrivano, E., Lylyk, N., Antonios, J., Beneduce, B., Levy, E., Heilman, C., Malek, A. Tags: SNIS 20th annual meeting oral abstracts Source Type: research